Trial Profile
A Single-Center, Non-Randomized, Open-Label, One-Sequence, Two-Period Within-Subject Study to Investigate the Effect of Itraconazole on the Pharmacokinetics of Multiple Doses of Balovaptan in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Sep 2020
Price :
$35
*
At a glance
- Drugs Balovaptan (Primary) ; Itraconazole
- Indications Autistic disorder
- Focus Pharmacokinetics
- Sponsors Genentech; Roche
- 15 Sep 2020 Results from two clinical studies: NCT03579719 and NCT03586726 published in the Advances in Therapy
- 14 Jan 2019 Status changed from recruiting to completed.
- 12 Jul 2018 New trial record